Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Study highlights cardio safety of Lilly GLP-1 dulaglutide
Pharma Times, UK
Wednesday, May 23, 2012 - 12:05pm
tags:
Eli Lilly, dulaglutide, diabetes
2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha
Wednesday, May 23, 2012 - 12:04pm
tags:
leukemia, Threshold Pharmaceuticals, Pharmacyclics, ibrutinib, chronic lymphocytic leukemia, TH-302
NovaBay's Market Cap Doesn't Adequately Value Pipeline Potential
Seeking Alpha
Wednesday, May 23, 2012 - 11:59am
tags:
NovaBay
Novo Nordisk Diabetes Drug Approved For Toddlers
Investors.com
Wednesday, May 23, 2012 - 11:52am
tags:
diabetes, Novo Nordisk, Levemir
Bill introduced to curb practices of "gray marketers" price-gouging on short-supply medicines
Yahoo/AP
Wednesday, May 23, 2012 - 11:50am
tags:
price gouging, gray marketers
Synergy Pharmaceuticals May Be Ready To Roll
Seeking Alpha
Wednesday, May 23, 2012 - 11:49am
tags:
Synergy Pharmaceuticals, plecanatide
Report Card: Johnson & Johnson And Selected Peers
Seeking Alpha
Wednesday, May 23, 2012 - 11:47am
tags:
JNJ, Abbott Laboratories, Bristol-Myers Squibb, Merck, Pfizer, Sanofi
Comparing 2 Dividend Plays In Healthcare
Seeking Alpha
Wednesday, May 23, 2012 - 11:45am
tags:
dividends, Pfizer, JNJ
Novo’s Insulin Pill Quest Is Holy Grail For Diabetics
Bloomberg
Wednesday, May 23, 2012 - 11:45am
tags:
insulin, diabetes, Novo Nordisk
Biotechs raise new VC rounds to back inhalable drugs, antimicrobials
Fierce Biotech
Tuesday, May 22, 2012 - 11:28am
tags:
Zurex Pharma, venture capital, Prosonix
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tuesday, May 22, 2012 - 11:25am
tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
Merck CEO: Generics, economy to make 2012-13 tough
Yahoo/AP
Tuesday, May 22, 2012 - 11:19am
tags:
Merck, generics, Kenneth Frazier, Pharma CEOs
FDA staff shoots down Pfizer rare disease drug
Yahoo/Reuters
Tuesday, May 22, 2012 - 11:19am
tags:
FDA, Pfizer, Vyndaqel, familial amyloid polyneuropathy
Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tuesday, May 22, 2012 - 11:16am
tags:
Medivation, Astellas, prostate cancer, Enzalutamide
Sales Rep Bans Are A Doubled-Edged Sword?
Pharmalot
Tuesday, May 22, 2012 - 10:03am
tags:
drug reps, physician access
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Tuesday, May 22, 2012 - 9:42am
tags:
Bayer, Onyx, Nexavar, lung cancer
InterMune to Sell Actimmune Rights
Yahoo/Zacks.com
Tuesday, May 22, 2012 - 9:40am
tags:
InterMune, Actimmune, Vidara, osteoporosis
Stem Cell Hype Has Yet To Breed Profits
Seeking Alpha
Tuesday, May 22, 2012 - 9:03am
tags:
stem cells, Geron, StemCells, Osiris, BioTime, Advanced Cell Technology
Brief Review Of A Few Biotechs
Seeking Alpha
Tuesday, May 22, 2012 - 8:58am
tags:
Amarin, Abbott Laboratories, Arena Pharmaceuticals, Osiris
Ampio Pharmaceuticals Is Positioned For A Rebound
Seeking Alpha
Tuesday, May 22, 2012 - 8:55am
tags:
Ampio Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.